Therefore, given that PSA is not cancer-specific and has a low positive predictive value of less than 25.0% for the detection of PCa4, there is a need for identifying useful markers as adjuncts to serum PSA levels for predicting clinically significant cancers, which thereby, can reduce the number of unnecessary prostate biopsies. The gene discussed is KLK3; the disease is cancer.